| Karin E Kerfoot, MD | |
|
60 Washington Ave, Suite 304, Hamden, CT 06518 | |
| (203) 281-2890 | |
| (203) 281-2896 |
| Full Name | Karin E Kerfoot |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 60 Washington Ave, Hamden, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881890242 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 044547 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karin E Kerfoot, MD 60 Washington Ave, 304, Hamden, CT 06518 Ph: (203) 281-2890 | Karin E Kerfoot, MD 60 Washington Ave, Suite 304, Hamden, CT 06518 Ph: (203) 281-2890 |
News Archive
The University of New Mexico Cancer Center is among a few select institutions nationwide participating in a Phase 3 clinical trial studying a novel treatment for men with newly diagnosed, localized prostate cancer.
Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.
A daily dose of safflower oil, a common cooking oil, for 16 weeks can improve such health measures as good cholesterol, blood sugar, insulin sensitivity and inflammation in obese postmenopausal women who have Type 2 diabetes, according to new research.
Scientists at The Scripps Research Institute have devised a powerful new technique for finding antibodies that have a desired biological effect. Antibodies, which can bind to billions of distinct targets, are already used in many of the world's best-selling medicines, diagnostics and laboratory reagents.
SGX-listed Singapore eDevelopment Limited's wholly owned subsidiary Impact Biomedical Inc. announced today that their COVID-19 research with Global Research and Discovery Group Sciences, conducted in collaboration with Harvard Medical School and Vilotos Pharmaceutical, Inc., was published in the peer-reviewed scientific journal Molecules on June 11, 2020.
› Verified 4 days ago
Samuel Leon Bridgers, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2080 Whitney Ave, Suite 280, Hamden, CT 06518 Phone: 203-248-6200 Fax: 203-248-5479 | |
George Davis Gammon, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 33 Edgehill Ter, Hamden, CT 06517 Phone: 203-865-6540 | |
Dr. Parkavi Chellappa, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9102 Town Walk Dr, Hamden, CT 06518 Phone: 520-437-1634 | |
Enrique J Tello, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 60 Washington Ave, Suite 304, Hamden, CT 06518 Phone: 203-281-2890 Fax: 203-281-2896 | |
Ezra Eh Griffith, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 95 Circular Ave, Hamden, CT 06514 Phone: 203-288-6253 Fax: 203-288-0948 | |
Brian Keyes, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1400 Whitney Ave, Hamden, CT 06517 Phone: 203-248-2116 Fax: 203-287-9815 | |
Lisa Fillmore, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 60 Washington Ave, Suite 304, Hamden, CT 06518 Phone: 203-281-2890 Fax: 203-281-2896 |